Unknown

Dataset Information

0

Targeting endosialin/CD248 through antibody-mediated internalization results in impaired pericyte maturation and dysfunctional tumor microvasculature.


ABSTRACT: Over-expression of endosialin/CD248 (herein referred to as CD248) has been associated with increased tumor microvasculature in various tissue origins which makes it an attractive anti-angiogenic target. In an effort to target CD248, we have generated a human CD248 knock-in mouse line and MORAb-004, the humanized version of the mouse anti-human CD248 antibody Fb5. Here, we report that MORAb-004 treatment significantly impacted syngeneic tumor growth and tumor metastasis in the human CD248 knock-in mice. In comparison with untreated tumors, MORAb-004 treated tumors displayed overall shortened and distorted blood vessels. Immunofluorescent staining of tumor sections revealed drastically more small and dysfunctional vessels in the treated tumors. The CD248 levels on cell surfaces of neovasculature pericytes were significantly reduced due to its internalization. This reduction of CD248 was also accompanied by reduced ?-SMA expression, depolarization of pericytes and endothelium, and ultimately dysfunctional microvessels. These results suggest that MORAb-004 reduced CD248 on pericytes, impaired tumor microvasculature maturation and ultimately suppressed tumor development.

SUBMITTER: Rybinski K 

PROVIDER: S-EPMC4694842 | biostudies-other | 2015 Sep

REPOSITORIES: biostudies-other

altmetric image

Publications

Targeting endosialin/CD248 through antibody-mediated internalization results in impaired pericyte maturation and dysfunctional tumor microvasculature.

Rybinski Katherine K   Imtiyaz Hongxia Z HZ   Mittica Barrie B   Drozdowski Brian B   Fulmer James J   Furuuchi Keiji K   Fernando Shawn S   Henry Marianne M   Chao Qimin Q   Kline Brad B   Albone Earl E   Wustner Jason J   Lin JianMin J   Nicolaides Nicholas C NC   Grasso Luigi L   Zhou Yuhong Y  

Oncotarget 20150901 28


Over-expression of endosialin/CD248 (herein referred to as CD248) has been associated with increased tumor microvasculature in various tissue origins which makes it an attractive anti-angiogenic target. In an effort to target CD248, we have generated a human CD248 knock-in mouse line and MORAb-004, the humanized version of the mouse anti-human CD248 antibody Fb5. Here, we report that MORAb-004 treatment significantly impacted syngeneic tumor growth and tumor metastasis in the human CD248 knock-i  ...[more]

Similar Datasets

| S-EPMC5617663 | biostudies-literature
| S-EPMC5520106 | biostudies-literature
| S-EPMC4908374 | biostudies-literature
| S-EPMC7990255 | biostudies-literature
| S-EPMC3101824 | biostudies-literature
2013-12-31 | E-GEOD-47064 | biostudies-arrayexpress
| S-EPMC10578441 | biostudies-literature
| S-EPMC4440614 | biostudies-literature
| S-EPMC5220675 | biostudies-literature
| S-EPMC4130531 | biostudies-literature